Patent: 7,364,736
✉ Email this page to a colleague
Summary for Patent: 7,364,736
Title: | Antibodies to OPGL |
Abstract: | Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are described. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are described. |
Inventor(s): | Boyle; William J. (Thousand Oaks, CA), Martin; Francis H. (Newbury Park, CA), Corvalan; Jose R. (Foster City, CA), Davis; C. Geoffrey (Burlingame, CA) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) Amgen Fremont Inc. (Fremont, CA) |
Application Number: | 10/180,648 |
Patent Claims: | see list of patent claims |
Details for Patent 7,364,736
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 06/01/2010 | ⤷ Try a Trial | 2021-06-26 |
Amgen, Inc. | XGEVA | denosumab | Injection | 125320 | 11/18/2010 | ⤷ Try a Trial | 2021-06-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,364,736
Country | Patent Number | Estimated Expiration |
---|---|---|
Argentina | 034637 | ⤷ Try a Trial |
Austria | 464068 | ⤷ Try a Trial |
Australia | 2002320157 | ⤷ Try a Trial |
Australia | 2008261137 | ⤷ Try a Trial |
Australia | 2012216429 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |